These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30514656)

  • 1. FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis.
    Albrecht F; Ballarini T; Neumann J; Schroeter ML
    Neuroimage Clin; 2019; 21():101594. PubMed ID: 30514656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
    Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined
    Aparicio J; Carreño M; Bargalló N; Setoain X; Rubí S; Rumià J; Falcón C; Calvo A; Martí-Fuster B; Padilla N; Boget T; Pintor L; Donaire A
    Neuroimage Clin; 2016; 12():976-989. PubMed ID: 27995064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.
    Sintini I; Schwarz CG; Martin PR; Graff-Radford J; Machulda MM; Senjem ML; Reid RI; Spychalla AJ; Drubach DA; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2019 Apr; 40(5):1618-1631. PubMed ID: 30549156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment.
    Pu W; Shen X; Huang M; Li Z; Zeng X; Wang R; Shen G; Yu H
    Curr Neurovasc Res; 2020; 17(4):480-486. PubMed ID: 32875986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis.
    Renard D; Vandenberghe R; Collombier L; Kotzki PO; Pouget JP; Boudousq V
    J Neurol; 2013 Dec; 260(12):3055-64. PubMed ID: 24068371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.
    Krämer J; Lueg G; Schiffler P; Vrachimis A; Weckesser M; Wenning C; Pawlowski M; Johnen A; Teuber A; Wersching H; Meuth SG; Duning T
    J Alzheimers Dis; 2018; 63(1):239-253. PubMed ID: 29614640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the posterior cingulate region with FDG-PET and advanced MR techniques in patients with amnestic mild cognitive impairment: comparison of the methods.
    Zimny A; Bladowska J; Macioszek A; Szewczyk P; Trypka E; Wojtynska R; Noga L; Leszek J; Sasiadek M
    J Alzheimers Dis; 2015; 44(1):329-38. PubMed ID: 24614904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET.
    Buhour MS; Doidy F; Laisney M; Pitel AL; de La Sayette V; Viader F; Eustache F; Desgranges B
    Brain Imaging Behav; 2017 Feb; 11(1):240-252. PubMed ID: 26852326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
    Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients.
    Shepherd TM; Nayak GK
    Top Magn Reson Imaging; 2019 Dec; 28(6):299-310. PubMed ID: 31794502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
    Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
    Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction.
    Maier F; Greuel A; Hoock M; Kaur R; Tahmasian M; Schwartz F; Csoti I; Jessen F; Drzezga A; van Eimeren T; Timmermann L; Eggers C
    Psychol Med; 2023 Mar; 53(4):1244-1253. PubMed ID: 37010224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Structural and Functional Brain Changes in Mild Cognitive Impairment: A Whole Brain ALE Meta-Analysis for Multimodal MRI.
    Gu L; Zhang Z
    ACS Chem Neurosci; 2019 Jun; 10(6):2823-2829. PubMed ID: 30808171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
    Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.